What is the current Alpha Emitters market size?

The Alpha Emitters market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Alpha Emitters market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Alpha Emitters market?

Key drivers include rising cancer incidence and advancements in nuclear medicine, fueling future outlook.

What challenges does the Alpha Emitters market face?

Challenges include high production costs, limited supply, and stringent regulatory requirements, impacting growth.

Which regions are leading the Alpha Emitters market?

North America and Europe are regional leaders, driven by strong healthcare infrastructure and research initiatives.

Who are the top companies in the Alpha Emitters market?

Key players include leading pharmaceutical and biotech companies, such as Bayer and Novartis, driving innovation.

What future opportunities exist in the Alpha Emitters market?

Emerging opportunities include targeted alpha therapy and increasing adoption in developing regions, driving market expansion.

How does technology impact the Alpha Emitters market?

Advances in technology, such as improved production methods, are enhancing efficiency and reducing costs, benefiting market growth.

What is the regulatory landscape for the Alpha Emitters market?

The regulatory landscape is complex, with strict guidelines from agencies such as the FDA, ensuring safety and efficacy.

What is the current Alpha Emitters market trend?

The current trend is focused on developing innovative treatments, such as cancer therapies, using alpha emitters, driving market future outlook.

What Is the Global Alpha Emitters Market Worth in 2026?

Alpha Emitters by Application (Hospitals, Medical Research Institutions, Others), by Types (Terbium (Tb-149), Astatine (At-211), Bismuth (Bi-212), Actinium (Ac-225), Radium (Ra-223), Lead (Pb-212), Bismuth (Bi-213)), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Alpha Emitters Market Size | CAGR 12.8 Forecast 2033

What Is the Global Alpha Emitters Market Worth in 2026?

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Alpha Emitters Market Overview

The Alpha Emitters market refers to the industry involved in the development and application of alpha-emitting isotopes, which have numerous applications in medical, industrial, and research fields. As the Alpha Emitters market size is anticipated to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a significant expansion driven by increasing demand for cancer treatments and emerging technologies. The industry expansion is expected to be fueled by advancements in nuclear medicine, radiation therapy, and medical imaging, with the global market projected to grow at a CAGR of 7.5% from 2026 to 2033.

Loading chart…

The Alpha Emitters market is shaped by key forces such as technology shifts, including the development of new radiopharmaceuticals and radiation therapy techniques, regulations, such as those related to nuclear safety and environmental protection, and consumer behavior, driven by increasing awareness of cancer treatments and medical imaging options. The largest region in the Alpha Emitters market is North America, while the fastest-growing region is Asia-Pacific, driven by emerging economies and increasing investments in nuclear medicine and radiation therapy. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, challenges, and opportunities in the Alpha Emitters market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bayer; Alpha Tau Medical; IBA RadioPharma; Actinium Pharmaceuticals; Telix Pharmaceuticals; RadioMedix; Fusion Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Alpha Emitters market is poised for significant growth, driven by increasing demand for cancer treatment and nuclear medicine applications. This section provides an in-depth analysis of the market dynamics, including growth drivers, restraints, opportunities, and challenges that are expected to shape the Alpha Emitters market size and growth forecast.

Growth Drivers2 items

Increasing adoption of Targeted Alpha Therapy (TAT) for cancer treatment, driven by its efficacy in treating various types of cancer, including prostate, breast, and ovarian cancer, is expected to drive the Alpha Emitters market size.

Advances in nuclear technology and the development of new Alpha Emitters, such as Actinium-225 and Bismuth-213, are expanding the range of applications and driving growth in the Alpha Emitters market.

Restraints2 items

High production costs and limited availability of certain Alpha Emitters, such as Radium-223, are significant restraints on the growth of the Alpha Emitters market size and growth forecast.

Stringent regulatory requirements and safety concerns associated with the handling and storage of Alpha Emitters are also limiting the adoption of these isotopes in various applications.

Opportunities2 items

The growing demand for Alpha Emitters in immunotherapy and combination therapies is creating new opportunities for market players to develop innovative products and treatments.

Emerging markets, such as Asia-Pacific, offer significant growth opportunities for the Alpha Emitters market, driven by increasing investments in nuclear medicine and cancer research.

Challenges2 items

The competitive landscape of the Alpha Emitters market is characterized by intense competition among market players, which can make it challenging for new entrants to establish themselves.

The Alpha Emitters market is also subject to macroeconomic factors, such as fluctuations in uranium prices and changes in government policies, which can impact the growth forecast and market size.

Market Segmentation

Loading chart…

The Alpha Emitters market can be segmented based on Application, which is a critical aspect of Alpha Emitters segmentation. This market segmentation involves categorizing the market into various application areas, including cancer treatment, research, and industrial applications. Each application area contributes to the overall Alpha Emitters market size, with cancer treatment being a significant segment. The application segment is expected to drive the growth of the Alpha Emitters market, with the increasing demand for targeted cancer therapies.

Another crucial segmentation category for the Alpha Emitters market is Types, which includes subtypes such as Radium-223, Actinium-225, and Bismuth-213. Each subtype has its unique characteristics, advantages, and limitations, contributing to the overall market size. The Types segment is essential in understanding the market taxonomy, as it helps analyze the market's competitive landscape and identify growth opportunities. The Alpha Emitters market is expected to witness significant growth in the coming years, driven by the increasing adoption of these subtypes in various applications.

Alpha Emitters Segmentation Breakdown12 items

Application

Hospitals

Medical Research Institutions

Others

Types

Terbium (Tb-149)

Astatine (At-211)

Bismuth (Bi-212)

Actinium (Ac-225)

Radium (Ra-223)

Lead (Pb-212)

Bismuth (Bi-213)

Regional Insights

Loading chart…

The Alpha Emitters market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, driven by increasing adoption of alpha emitters in cancer treatment, government policies supporting nuclear medicine, and investments in healthcare infrastructure. The fastest-growing region is expected to be Latin America, driven by growing demographics, expanding ecosystem maturity, and rising investments in nuclear medicine.

In North America, key drivers include established infrastructure, high adoption rates, and ongoing research in alpha emitters. Europe is driven by stringent policies, high ecosystem maturity, and significant investments in healthcare. Asia Pacific is driven by large demographics, growing adoption, and increasing investments in nuclear medicine. Latin America is driven by growing demographics, expanding ecosystem maturity, and rising investments in healthcare. Middle East & Africa is driven by growing adoption, increasing investments, and improving infrastructure.

The regional forecast indicates that the Alpha Emitters market growth will be influenced by factors such as adoption, policies, investments, demographics, infrastructure, and ecosystem maturity. Understanding these factors is crucial for stakeholders to navigate the regional landscape and capitalize on emerging opportunities.

Competitive Landscape

The Alpha Emitters market is moderately consolidated, driven by a mix of global players and local companies. The Alpha Emitters competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies in the Alpha Emitters market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To overcome these challenges, companies focus on competitive differentiation through technology, service models, channel strength, customization, and cost advantages.

Bayer: regional expansion

Alpha Tau Medical: innovation pipeline

IBA RadioPharma: vertical integration

Actinium Pharmaceuticals: premium pricing

Telix Pharmaceuticals: OEM tie-ups

Fusion Pharmaceuticals: local manufacturing

Key Alpha Emitters Companies7 items

Bayer

Alpha Tau Medical

IBA RadioPharma

Actinium Pharmaceuticals

Telix Pharmaceuticals

RadioMedix

Fusion Pharmaceuticals

Market Ecosystem

The Alpha Emitters ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main tiers: upstream, midstream, and downstream. Upstream participants, such as raw material suppliers and technology providers, create the foundational components and technologies that are then integrated by midstream participants, including manufacturers and system integrators. Finally, downstream channels and end users ultimately capture the value created through the Alpha Emitters value chain analysis.

Raw material/component suppliers — provide essential materials

Technology providers — develop core technologies

OEMs / manufacturers — produce final products

System integrators / EPCs — integrate Alpha Emitters into systems

Distributors / channel partners — facilitate product distribution

Regulators/standards bodies — establish and enforce standards

End users / buyers — utilize Alpha Emitters in various applications

Value flows through the Alpha Emitters ecosystem as participants interact and exchange goods, services, and information. Control points, such as regulatory bodies and large manufacturers, can significantly influence adoption and development of Alpha Emitters. Dependency risks, including input constraints and standards approvals, can also impact the ecosystem. Switching costs and partnerships may be high due to the specialized nature of Alpha Emitters, and interoperability requirements can vary by region. As the Alpha Emitters ecosystem differs by region, with diverse areas exhibiting unique characteristics, understanding these dynamics is crucial for navigating the complex web of relationships within the ecosystem.

Recent Industry Insights

The Alpha Emitters industry has witnessed significant developments over the last 12-18 months, shaping the Alpha Emitters industry trends. Recent partnerships have focused on enhancing research and development capabilities, with companies collaborating to advance the use of alpha emitters in cancer treatment. Notable mergers and acquisitions have also taken place, leading to consolidation and increased investment in the sector. Furthermore, several product and technology launches have improved the efficacy and safety of alpha emitter-based therapies.

Regulatory changes have supported the growth of the Alpha Emitters market, with updated guidelines facilitating the approval of new treatments. A shift in consumer and enterprise trends has also been observed, with a growing demand for targeted and personalized therapies. Additionally, funding rounds and expansions have provided companies with the necessary resources to drive innovation and commercialization, ultimately influencing the future of Alpha Emitters industry trends.

Analyst Overview

As the Lead Analyst for this study, my expert view on the Alpha Emitters market is that it presents a highly attractive opportunity for investors and industry players. The Alpha Emitters market outlook is promising, driven by increasing demand for targeted therapies and advancements in nuclear medicine. The competitive intensity is moderate, with key players focusing on innovation and strategic partnerships to gain market share.

The long-term outlook for the Alpha Emitters market is positive, with a growing need for innovative cancer treatments and diagnostic tools. The innovation landscape is dynamic, with ongoing research and development in radiopharmaceuticals and radiotherapy. However, the demand–supply balance may be affected by key risk factors, including regulatory hurdles and supply chain disruptions, which must be carefully managed to ensure sustainable growth.

11 items

1. Executive Summary

2. Alpha Emitters Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Alpha Emitters Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Alpha Emitters Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Medical Research Institutions

6.1.3. Others

6.2. Global Alpha Emitters Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Terbium (Tb-149)

6.2.2. Astatine (At-211)

6.2.3. Bismuth (Bi-212)

6.2.4. Actinium (Ac-225)

6.2.5. Radium (Ra-223)

6.2.6. Lead (Pb-212)

6.2.7. Bismuth (Bi-213)

6.3. Global Alpha Emitters Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Alpha Emitters Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Alpha Emitters Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Alpha Emitters Market Competition by Key Manufacturers

8.1. Global Alpha Emitters Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Alpha Emitters: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Bayer

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Alpha Tau Medical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. IBA RadioPharma

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Actinium Pharmaceuticals

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Telix Pharmaceuticals

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. RadioMedix

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Fusion Pharmaceuticals

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Alpha Emitters Market

Figure 4: Global Alpha Emitters Market: Drivers

Figure 5: Global Alpha Emitters Market: Challenges

Figure 6: Global Alpha Emitters Market: Trends

Figure 7: Global Alpha Emitters Market: Opportunity

Figure 8: Global Alpha Emitters Market: Restraint

Figure 9: Global Alpha Emitters Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Alpha Emitters Market Value (USD Million) By Region

Figure 15: Global Alpha Emitters Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Alpha Emitters Market Value (USD Million) By Region

Figure 23: Global Alpha Emitters Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Alpha Emitters Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Alpha Emitters Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Alpha Emitters Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Alpha Emitters Market Value (USD Million) By Region

Table 10: Global Alpha Emitters Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Alpha Emitters Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Alpha Emitters Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Alpha Emitters Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Bayer Basic Information And Sales Area

Table 31: Bayer. Products Portfolio

Table 32: Alpha Tau Medical Basic Information And Sales Area

Table 33: Alpha Tau Medical. Products Portfolio

Table 34: IBA RadioPharma Basic Information And Sales Area

Table 35: IBA RadioPharma. Products Portfolio

Table 36: Actinium Pharmaceuticals Basic Information And Sales Area

Table 37: Actinium Pharmaceuticals. Products Portfolio

Table 38: Telix Pharmaceuticals Basic Information And Sales Area

Table 39: Telix Pharmaceuticals. Products Portfolio

Table 40: RadioMedix Basic Information And Sales Area

Table 41: RadioMedix. Products Portfolio

Table 42: Fusion Pharmaceuticals Basic Information And Sales Area

Table 43: Fusion Pharmaceuticals. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Alpha Emitters Market Value (USD Million) By Region

Table 49: Global Alpha Emitters Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Alpha Emitters Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bayer; Alpha Tau Medical; IBA RadioPharma; Actinium Pharmaceuticals; Telix Pharmaceuticals; RadioMedix; Fusion Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options